The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases (Q35145713)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases |
scientific article |
Statements
1 reference
The potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseases (English)
1 reference
Brigitta E Miyamoto
1 reference
Emil D Kakkis
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference